Companies:
50,383
Total Market Cap:
144476471981098.74
Global Rank
#14430
Country Rank
#348
Market Cap
504.47 M
Price
78.39
Change (%)
1.36%
Volume
5,949
Dong-A Socio Holdings's latest marketcap:
504.47 M
As of 08/19/2025, Dong-A Socio Holdings's market capitalization has reached $504.47 M. According to our data, Dong-A Socio Holdings is the 14430th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 504.47 M |
| Revenue (ttm) | 977.46 M |
| Net Income (ttm) | 49.03 M |
| Shares Out | 6.44 M |
| EPS (ttm) | 7.61 |
| Forward PE | 7.03 |
| Ex-Dividend Date | 07/30/2025 |
| Earnings Date | 07/29/2025 |
Market Cap Chart
Data Updated: 08/19/2025
Dong-A Socio Holdings's yearly market capitalization.
Dong-A Socio Holdings has seen its market value grow from ₩539.89 B to ₩700.21 B since 2014, representing a total increase of 29.69% and an annual compound growth rate (CAGR) of 2.47%.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/19/2025 | ₩700.21 B | $504.47 M | 3.43% | 14430 |
| 12/30/2024 | ₩686.33 B | $459.84 M | 8.71% | 13543 |
| 12/28/2023 | ₩631.32 B | $486.12 M | -0.49% | 13198 |
| 12/29/2022 | ₩634.45 B | $501.21 M | -11.72% | 12236 |
| 12/30/2021 | ₩718.67 B | $603.68 M | -4.69% | 12200 |
| 12/30/2020 | ₩754 B | $693.68 M | 14.27% | 9821 |
| 12/30/2019 | ₩659.87 B | $567.49 M | -1.38% | 9401 |
| 12/28/2018 | ₩669.07 B | $595.48 M | -14.84% | 8242 |
| 12/28/2017 | ₩785.69 B | $730.69 M | -17.02% | 8588 |
| 12/29/2016 | ₩946.87 B | $776.44 M | 20.98% | 7620 |
Company Profile
About Dong-A Socio Holdings Co., Ltd.
Dong-A Socio Holdings Co., Ltd., along with its subsidiaries, operates as a key player in South Korea's pharmaceutical and healthcare industry. The company is structured into multiple segments to streamline its diverse operations.
Business Segments
- Holding Company – Oversees corporate strategy and subsidiary management.
- Over-the-Counter Drugs and Quai-Drugs – Provides accessible healthcare solutions.
- Biosimilars and Consignment Medicines – Focuses on developing biosimilar treatments.
- Logistics – Manages supply chain and distribution.
- Packaging Solutions – Offers packaging for pharmaceuticals and beverages.
- Others – Includes IT, construction, and real estate services.
Key Products & Developments
- DA-8010 – Phase 3 clinical trial for overactive bladder treatment.
- DMB-3115 – Biosimilar of Stelara in Phase 3 trials.
- DA-1241 – Phase 2 trial for non-alcoholic steatohepatitis.
- DA-1726 – Phase 1 obesity treatment.
- STP0404 – AIDS treatment under development.
Additional Offerings
- Medical devices and healthcare solutions.
- Functional sports drinks (POCARI SWEAT brand).
- Contract manufacturing for biosimilars and oligonucleotide therapeutics.
- Logistics, packaging, and fulfillment services.
- Beverages, including mineral water and carbonated drinks.
- Real estate, consulting, and construction services.
Founded: 1932 | Headquarters: Seoul, South Korea
Frequently Asked Questions
-
What is Dong-A Socio Holdings's (KRX-000640) current market cap?As of 08/19/2025, Dong-A Socio Holdings (including the parent company, if applicable) has an estimated market capitalization of $504.47 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dong-A Socio Holdings (KRX-000640) rank globally by market cap?Dong-A Socio Holdings global market capitalization ranking is approximately 14430 as of 08/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.